Skip to main content
. 2017 Dec 12;7:17419. doi: 10.1038/s41598-017-17232-1

Figure 2.

Figure 2

In vitro antibacterial activity of γ-ACT. (a) MICs (µg/ml) of γ-ACT against a panel of Gram-positive and Gram-negative bacteria. (b) MICs (µg/ml) for γ-ACT against a collection (n = 70) of clinical isolates of S. aureus comprising strains that are methicillin sensitive (MSSA), methicillin resistant (MRSA), and vancomycin intermediate (VISA). The central pie chart shows a breakdown of these different strain types in the collection, whilst the outer charts indicate the proportion of isolates susceptible to different concentrations of γ-ACT.